Artificial intelligence improves accuracy in estimating child abuse
New model refines prevalence estimates, reduces misdiagnoses compared to the current coding system.
ADHD Medications: A Look at Their Safety Profile
Each year in this country, physicians prescribe medications to treat ADHD in nearly 3 million children. The safety of these agents has been the subject of some debate.
Q1 2025: A recap of the top headlines and interviews
View our Q1 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.
Cingulate reports phase 3 safety data for CTx-1301 to treat ADHD in children, adolescents
Results will be included an a final analysis of safety and efficacy data for CTx-1301, which will be included in a NDA submission with the FDA, stated Cingulate Inc.
Study finds parents' screen habits shape kids' media exposure
Parents’ screen habits influence kids' media use, with bedroom and mealtime screen time increasing exposure to mature content.
ADHD with ASD and without it: Should they be treated differently?
"My takeaway is that if medicine is needed, stimulants will be my first choice in this age group, regardless of whether the ADHD coexists with ASD."
